Given the low MC we don't get much analyst coverage so I found this a little encouraging (small steps). I remember that Morgans ditched talking to and about PYC last year after becoming frustrated like all of us...
"I caught up with Richard Hopkins yesterday - Richard has recently taken over as CEO of Phylogica was formerly the COO. The message was fairly simple - focus on an area/s where can add real value to pharma - that value add seems to be getting drugs into cells - or as they have termed it (functional penetrating peptides). Sounds like pharma have a genuine interest working with PYC. Following a recent capital raising PYC has a two year run way with A$6m in bank. Share price looks much healthier and looks like heading higher."
PYC Price at posting:
3.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)